Invesaro

Stocks Health care INFU

NYSE · Health care

InfuSystem Holdings, Inc (INFU)

InfuSystem Holdings, Inc brought in $143.3M of revenue over the twelve months to June 30, 2026, up 2.5% from a year earlier. Net income was $8.5M, a net margin of 6.0%. Operating cash flow minus capital spending left $23.8M of free cash flow in fiscal 2025. At June 30, 2026 it held $964K in cash against $20.4M of debt. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 4, 2026.

Revenue (last 12 months)
$143.3M
+2.5% year on year
Net margin
6.0%

What InfuSystem Holdings, Inc does

InfuSystem Holdings, Inc is registered with the SEC under industry code SIC 3841 (Surgical & Medical Instruments & Apparatus). Its shares trade on NYSE under the ticker INFU.

Revenue and profit by year

Revenue
FY18: $67.1M $67.1M FY18FY19: $81.1M $81.1M FY19FY20: $97.4M $97.4M FY20FY21: $102.4M $102.4M FY21FY22: $109.9M $109.9M FY22FY23: $125.8M $125.8M FY23FY24: $134.9M $134.9M FY24FY25: $143.4M $143.4M FY25
Net income
FY18: -$1.1M -$1.1M FY18FY19: $1.4M $1.4M FY19FY20: $17.3M $17.3M FY20FY21: $1.4M $1.4M FY21FY22: $18K $18K FY22FY23: $872K $872K FY23FY24: $2.3M $2.3M FY24FY25: $6.6M $6.6M FY25

Fiscal years as reported in annual reports. Amounts in USD.

Key figures

Fiscal yearRevenueOperating incomeNet incomeDiluted EPSFree cash flow
2025$143.4M$11.9M$6.6M$0.31$23.8M
2024$134.9M$6.9M$2.3M$0.11$19.4M
2023$125.8M$4.1M$872K$0.04$10.2M
2022$109.9M$1.7M$18K$0.00$16.5M
2021$102.4M$2.8M$1.4M$0.06$17.3M
2020$97.4M$8.8M$17.3M$0.80$19.2M

Latest SEC filings

What InfuSystem Holdings, Inc has filed recently, newest first. Each links to the original document on SEC EDGAR.

  1. September 17, 2026
  2. August 4, 2026
    Quarterly report 10-Q · period to June 30, 2026
  3. August 4, 2026
  4. August 4, 2026
  5. July 28, 2026
  6. July 28, 2026
  7. May 18, 2026
  8. May 18, 2026
  9. May 14, 2026
  10. May 12, 2026

Recent insider filings (Forms 3, 4 and 144): 10, the latest on September 11, 2026. Insider transactions on SEC

All filings on SEC EDGAR

Questions about INFU

What does InfuSystem Holdings, Inc do?

InfuSystem Holdings, Inc is registered with the SEC under industry code SIC 3841 (Surgical & Medical Instruments & Apparatus). Its shares trade on NYSE under the ticker INFU.

Is InfuSystem Holdings, Inc profitable?

Yes. Over the twelve months to June 30, 2026 it reported net income of $8.5M on revenue of $143.3M, a net margin of 6.0%.

How much revenue does InfuSystem Holdings, Inc make?

Over the twelve months to June 30, 2026 InfuSystem Holdings, Inc reported revenue of $143.3M. That is 2.5% more than a year earlier.

When did InfuSystem Holdings, Inc last report?

Its most recent periodic report is the quarterly report (10-Q) filed on August 4, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the investor disclosure from September 17, 2026.

Similar companies

Follow INFU

Get an email when InfuSystem Holdings, Inc files with the SEC: results, executive changes, material agreements and annual reports.

Follow INFU: get an email when it files

Where the numbers come from

Financial figures are the values InfuSystem Holdings, Inc tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.

Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.